FIELD: medicine.
SUBSTANCE: presented methods for pancreatic cancer detection include measurement of the presence or amount of a polypeptide having a reactivity in the form of specific binding with the CAPRIN-1 protein antibody via antigen-antibody interaction, or the presence or amount of a nucleic acid encoding this polypeptide, in a sample derived from an individual, wherein the polypeptide to be measured is CAPRIN-1 protein consisting of the amino acid sequence corresponding to any of even-numbered SEQ ID NO: 2-30, and wherein the presence or amount of nucleic acid encoding the polypeptide is determined by the nucleic acid encoding the polypeptide contained in the sample.
EFFECT: invention allows simple detection of malignant tumours of pancreatic cancer.
27 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTION OF MALIGNANT TUMOURS | 2009 |
|
RU2519089C2 |
METHOD FOR DETECTING MALIGNANT TUMOURS | 2014 |
|
RU2671497C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2595400C2 |
METHOD FOR CANCER DETECTION | 2013 |
|
RU2646466C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2610428C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2012 |
|
RU2611197C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2624049C2 |
METHOD FOR CANCER DETECTION | 2013 |
|
RU2646464C2 |
PHARMACEUTICAL COMPOSITION FOR PANCREATIC CANCER TREATMENT AND/OR PREVENTION | 2012 |
|
RU2630638C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2641260C2 |
Authors
Dates
2017-06-30—Published
2012-08-03—Filed